Work

First-line ceritinib versus chemotherapy in patients (pts) with advanced ALK rearranged (ALK+) non-small cell lung cancer (NSCLC): ASCEND-4 Asian subgroup analysis

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz259.016

Authors: D.S. Tan, S. Geater, C.J. Yu, C.M. Tsai, T.C. Hsia, J. Zhou, J. Chen, M.C. Lin, P. Yu, J. He, W. Li, Y. Lu, V. Sriuranpong, C.T. Yang, P. Sen, F. Branle, M. Shi, Y.L. Wu

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2978069062

FWCI: 0.556

Cites:

Cited by: 3

Related to: 10